KR830001869A - 1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법 - Google Patents

1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법

Info

Publication number
KR830001869A
KR830001869A KR1019830000546A KR830000546A KR830001869A KR 830001869 A KR830001869 A KR 830001869A KR 1019830000546 A KR1019830000546 A KR 1019830000546A KR 830000546 A KR830000546 A KR 830000546A KR 830001869 A KR830001869 A KR 830001869A
Authority
KR
South Korea
Prior art keywords
compound
group
formula
hal
acylamido
Prior art date
Application number
KR1019830000546A
Other languages
English (en)
Other versions
KR840001964B1 (ko
Inventor
엘. 나가부산 타탄할리
Original Assignee
스타이나 칸스타트, 로즈마리 아이젠링
쉐링 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21736232&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR830001869(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 스타이나 칸스타트, 로즈마리 아이젠링, 쉐링 코포레이션 filed Critical 스타이나 칸스타트, 로즈마리 아이젠링
Publication of KR830001869A publication Critical patent/KR830001869A/ko
Application granted granted Critical
Publication of KR840001964B1 publication Critical patent/KR840001964B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
    • C07D499/58—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

내용 없음

Description

1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 일반식(Ⅱ)의 화합물을 산화시키거나, R이일반식(Ⅰ) 화합물을 중수소화 하여 R이일반식(Ⅰ)의 상응하는 듀테로 화합물을 생성하여, 이들을 유리형태 또는 약제학적으로 무독한 염 또는 에스테르로 분리하는 것을 특징으로 하여 일반식(Ⅰ)의-1-아릴-2-아실아미도-3-플루오로-1-프로판올 화합물 및 그의 약제학적으로 무독한 염을 제조하는 방법.
    상기 일반식에서
    R은 하나 이상의 할로겐 원소로 치환될 수 있는 탄소수 하나 또는 둘의 알킬그룹을 나타내거나, 메틸설포닐메틸 또는 할로겐 듀테로알킬 그룹
    (여기서 Y는 -CH3, -CH2Hal 또는 Hal이며, Hal은 할로겐 원자를 나타낸다)을 나타내며,
    X는 R1SO- 또는 R1SO2-를 나타내며, R1은 탄소수 1내지 3의 저급 알킬이며,
    Z는 수소 또는 탄소수 16까지인 카복실산의 아실라디칼이고,
    X′는 R1SO- 또는 R1SO2-그룹으로 전환될 수 있는 상응하는 그룹, R1S- 또는 R1SO-이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019830000546A 1979-02-05 1983-02-10 1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법 KR840001964B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/009,207 US4235892A (en) 1979-02-05 1979-02-05 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
US009,207 1979-02-05
US9207 1979-02-05
KR1019800000370A KR840001837B1 (ko) 1979-02-05 1980-01-31 1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1019800000370A Division KR840001837B1 (ko) 1979-02-05 1980-01-31 1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법

Publications (2)

Publication Number Publication Date
KR830001869A true KR830001869A (ko) 1983-05-19
KR840001964B1 KR840001964B1 (ko) 1984-10-26

Family

ID=21736232

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1019800000370A KR840001837B1 (ko) 1979-02-05 1980-01-31 1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법
KR1019830000545A KR840001963B1 (ko) 1979-02-05 1983-02-10 1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법
KR1019830000546A KR840001964B1 (ko) 1979-02-05 1983-02-10 1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법

Family Applications Before (2)

Application Number Title Priority Date Filing Date
KR1019800000370A KR840001837B1 (ko) 1979-02-05 1980-01-31 1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법
KR1019830000545A KR840001963B1 (ko) 1979-02-05 1983-02-10 1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법

Country Status (18)

Country Link
US (1) US4235892A (ko)
EP (1) EP0014437B1 (ko)
JP (1) JPS5923300B2 (ko)
KR (3) KR840001837B1 (ko)
AR (3) AR230260A1 (ko)
AT (1) ATE2616T1 (ko)
AU (1) AU532879B2 (ko)
CA (1) CA1137106A (ko)
DE (1) DE3062094D1 (ko)
DK (1) DK159264C (ko)
HU (1) HU180555B (ko)
IE (1) IE49740B1 (ko)
IL (1) IL59288A (ko)
MX (1) MX9203279A (ko)
MY (1) MY8500051A (ko)
NL (1) NL950004I2 (ko)
NZ (1) NZ192774A (ko)
ZA (1) ZA80478B (ko)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130633B1 (en) * 1983-06-02 1996-10-09 ZAMBON GROUP S.p.A. Process for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoro propane derivatives
IT1173213B (it) * 1984-02-03 1987-06-18 Zambon Spa Procedimento per fluorurare alcuni derivati dall'1l-fenil-2-ammino-1,3-propandiolo e loro intermedi
US5243056A (en) * 1983-06-02 1993-09-07 Zambon S.P.A. Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoro propane derivatives
US5105009A (en) * 1983-06-02 1992-04-14 Zambon S.P.A. Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives
GB8322983D0 (en) * 1983-08-26 1983-09-28 Pfizer Ltd Triazole antifungal agents
US5153328A (en) * 1984-02-03 1992-10-06 Zambon S.P.A. 2 Hydrocarbyl-4 substituted methyl 5 (4 substituted phenyl)-oxazolines
US5332835A (en) * 1984-02-03 1994-07-26 Zambon S.P.A. Process for fluorinating 1-phenyl-2-amino-1,3-propanediol compounds and new oxazoline compounds useful in this process
US4582918A (en) * 1984-09-19 1986-04-15 Schering Corporation Preparation of intermediates for (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
US4973750A (en) * 1984-09-19 1990-11-27 Schering Corporation Preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
DE3543021A1 (de) * 1985-12-05 1987-06-11 Boehringer Mannheim Gmbh Verbesserte verfahren zur herstellung von d-threo-1-(p-methylsulfonylphenyl) -2-dichloracetamido-propandiol-1,3-(thiamphenicol) sowie verwendung geeigneter zwischenprodukte
IT1197481B (it) * 1986-09-15 1988-11-30 Zambon Spa Preparazione farmaceutica per uso veterinario
IT1198238B (it) * 1986-12-23 1988-12-21 Zambon Spa Composti ad attivita' antibiotica
DE3800474A1 (de) * 1988-01-11 1989-07-20 Basf Lacke & Farben Verfahren und vorrichtung zum messen der viskositaet von stoffen
US5227494A (en) * 1988-09-14 1993-07-13 Schering Corporation Process for preparing oxazoline compounds
US4876352A (en) * 1988-09-14 1989-10-24 Schering Corporation Pressurized fluorination of hydroxy alkyl groups
IT1237798B (it) * 1989-10-20 1993-06-17 Zambon Spa Processo per l'inversione stereochimica di (2s,3s)-2-ammino-3-fenil-1 ,3-propandioli nei corrispondenti enantiomeri (2r,3r).
IT1240676B (it) * 1990-04-24 1993-12-17 Agrimont Spa Composizioni ad attivita' erbicida
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
PL166385B1 (en) * 1990-10-25 1995-05-31 Schering Corp Method of obtaining oxazoline compound
US5039666A (en) * 1990-10-30 1991-08-13 Hoechst-Roussel Pharmaceuticals Inc. Aminoglycoside composition having substantially reduced nephrotoxicity induced by the aminoglycoside
IT1249048B (it) 1991-02-21 1995-02-11 Zambon Spa Processo per la preparazione di trans-(5r)-2-ossazoline -2,4,5, trisostituite
US5346828A (en) * 1991-03-27 1994-09-13 Celgene Corporation Stereoisomeric enrichment of 2-amino-3-hydroxy-3-phenylpropionic acids using d-threonine aldolase
US5352832A (en) * 1992-12-18 1994-10-04 Schering Corporation Asymmetric process for preparing florfenicol, thiamphenicol chloramphenicol and oxazoline intermediates
DE4437932A1 (de) * 1994-10-24 1996-04-25 Bayer Ag Verfahren zur Herstellung von in einer Seitenkette fluorierten Alkyloxazolen und neue, in einer Seitenkette fluorierte Alkyloxazole
US6432203B1 (en) * 1997-03-17 2002-08-13 Applied Komatsu Technology, Inc. Heated and cooled vacuum chamber shield
US6150423A (en) 1998-10-15 2000-11-21 Phoenix Scientific, Inc. Propofol-based anesthetic and method of making same
US20030068339A1 (en) * 2001-10-02 2003-04-10 Phoenix Scientific, Inc. Veterinary florfenicol formulation that is syringeable under cold weather conditions
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
IL163749A0 (en) * 2002-03-08 2005-12-18 Schering Plough Ltd Novel florfenicol-type antibiotics
KR100896646B1 (ko) * 2002-08-21 2009-05-08 주식회사 포스코 스트립 산세조의 스트립 리프터를 이용한 염산액자동샘플링 장치
AR044437A1 (es) 2003-05-29 2005-09-14 Schering Plough Ltd Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino
US8273371B2 (en) * 2003-06-27 2012-09-25 Johan Adriaan Martens Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs
GB0315012D0 (en) * 2003-06-27 2003-07-30 Leuven K U Res & Dev Zeotiles
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
EP1502589B1 (en) * 2003-07-31 2006-05-31 Emdoka bvba, Drug registration and Marketing Veterinary aqueous injectable suspensions containing florfenicol
US20050049210A1 (en) * 2003-08-27 2005-03-03 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
US7126005B2 (en) 2003-10-06 2006-10-24 Aurobindo Pharma Limited Process for preparing florfenicol
TWI262181B (en) * 2003-12-23 2006-09-21 Schering Plough Ltd Florfenicol prodrug having improved water solubility
WO2005066119A2 (en) * 2003-12-31 2005-07-21 Schering-Plough Ltd. Antibacterial 1-(4-mono-and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoropropanols and preparation thereof
PL1776109T3 (pl) * 2004-08-13 2009-06-30 Schering Plough Ltd Farmaceutyczna formulacja zawierająca antybiotyk, triazol i kortykosteroid
EP1836162A2 (en) * 2004-09-02 2007-09-26 IDEXX Laboratories Inc Antibacterial agents
AU2005318187B2 (en) * 2004-12-21 2010-12-16 Intervet International B.V. Injectable veterinary composition
EP1785414A1 (en) * 2005-11-09 2007-05-16 KRKA, tovarna zdravil, d.d., Novo mesto Process for the synthesis of intermediates of chloramphenicol or its analogues
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US7518017B2 (en) 2006-02-17 2009-04-14 Idexx Laboratories Fenicol compounds and methods synthesizing 2-trifluoroacetamido-3-substituted propiophenone compounds
GB0612695D0 (en) * 2006-06-27 2006-08-09 Univ Gent Process for preparing a solid dosage form
CA2672586A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of florfenicol and its analogs
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
PE20091171A1 (es) * 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol
AU2009264307A1 (en) 2008-06-24 2009-12-30 Intervet International B.V. Pharmaceutical transdermal compositions and method for treating inflammation in cattle
CN102131772B (zh) * 2008-07-30 2015-03-11 英特威国际有限公司 用作氟苯尼考的中间体的*唑啉-保护的氨基二醇化合物的制备方法
CN101337916B (zh) * 2008-08-12 2011-02-16 张家港市恒盛药用化学有限公司 氟苯尼考磺酸酯及其盐以及它们的制备方法
CN103649097A (zh) 2011-05-02 2014-03-19 佐蒂斯有限责任公司 用作抗菌剂的新型头孢菌素类
CN102491953A (zh) * 2011-12-05 2012-06-13 江西日上化工有限公司 一种合成氟苯尼考中间体rt0131的方法
PL2986592T3 (pl) * 2013-04-17 2018-07-31 Zoetis Services Llc Nowe fenikolowe środki przeciwbakteryjne
CN103965085B (zh) * 2014-04-17 2016-02-24 上海恒晟药业有限公司 一种取代1,2-氨基醇药物的制备方法
CN106770599A (zh) * 2016-12-08 2017-05-31 哈尔滨工业大学 一种测定镀铬板裸露铁程度的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2727070A (en) * 1950-02-25 1955-12-13 Parke Davis & Co Substituted propanols and processes for their manufacture
US2727071A (en) * 1950-06-16 1955-12-13 Parke Davis & Co Process for obtaining substituted chloropropanols from oxazolines
US2759971A (en) * 1951-10-01 1956-08-21 Sterling Drug Inc 2-amino and acylamino-1-(hydrocarbylmercaptophenyl)-1, 3-propanediols and preparation thereof
US2759972A (en) * 1951-10-01 1956-08-21 Sterling Drug Inc 2-amino and acylamino-1-(hydrocarbylsulphonylphenyl)-1, 3-propanediols
US2717268A (en) * 1952-12-16 1955-09-06 Parke Davis & Co Process for preparing phenyldichloro-acetamidopropanediols
US2876261A (en) * 1955-09-15 1959-03-03 Parke Davis & Co Alpha-di-chloroacetamido-beta-chloro-p-nitropropiophenone and method of production
US2759927A (en) * 1955-12-27 1956-08-21 Sterling Drug Inc Hexamethylenetetramine adducts of haloaceto-mercaptophenones
US2776992A (en) * 1956-03-14 1957-01-08 Du Pont Trifluoromethylsulfonylphenyldichloracetamidopropandiol
US2759970A (en) * 1956-05-09 1956-08-21 Sterling Drug Inc Acylamidoaceto-mercaptophenones
US3012073A (en) * 1960-04-11 1961-12-05 Du Pont Trifluoro methylthiophenyl-dichloro-acet-amides-1, 3-propanediol
NL130756C (ko) * 1964-03-02

Also Published As

Publication number Publication date
HU180555B (en) 1983-03-28
CA1137106A (en) 1982-12-07
DK42480A (da) 1980-08-06
NL950004I2 (nl) 1998-04-01
US4235892A (en) 1980-11-25
EP0014437B1 (en) 1983-02-23
EP0014437A2 (en) 1980-08-20
MY8500051A (en) 1985-12-31
KR840001963B1 (ko) 1984-10-26
NL950004I1 (nl) 1995-05-01
AR230427A1 (es) 1984-04-30
AR230428A1 (es) 1984-04-30
ZA80478B (en) 1981-01-28
IL59288A (en) 1984-06-29
AU5507880A (en) 1980-07-10
JPS55115855A (en) 1980-09-06
DK159264B (da) 1990-09-24
AR230260A1 (es) 1984-03-01
DE3062094D1 (en) 1983-03-31
DK159264C (da) 1991-02-18
AU532879B2 (en) 1983-10-20
KR830001867A (ko) 1983-05-19
KR830001868A (ko) 1983-05-19
KR840001837B1 (ko) 1984-10-22
JPS5923300B2 (ja) 1984-06-01
NZ192774A (en) 1984-08-24
EP0014437A3 (en) 1980-10-29
ATE2616T1 (de) 1983-03-15
IE49740B1 (en) 1985-12-11
KR840001964B1 (ko) 1984-10-26
IE800198L (en) 1980-08-05
IL59288A0 (en) 1980-05-30
MX9203279A (es) 1992-07-31

Similar Documents

Publication Publication Date Title
KR830001869A (ko) 1-아릴-2-아실아미도-3-플루오로-1-프로판올의 제조방법
KR850000406A (ko) 4-클로로-2-페닐이미다졸-5-아세트산유도체의 제조방법
KR890003668A (ko) 플루오르화 벤조일 화합물
KR830004292A (ko) 벤조구아나민 유도체의 제조방법
KR830001936A (ko) 벤조디아제핀 유도체의 제조방법
KR830006302A (ko) 신규 피리미딘 유도체의 제조방법
KR830008990A (ko) 2-아미노-3-(할로벤조일)-메틸페닐아세트산 유도체의 제조방법
KR850004470A (ko) 유기 화합물의 제조방법
KR840001160A (ko) 벤조디옥산-이미다졸린 유도체의 제조방법
KR840009282A (ko) 스티렌 유도체의 제조방법
KR830003460A (ko) 면역조절 활성을 갖는 치환된 피페라진 및 피페리딘
KR830007693A (ko) 7-아미노 세펨 화합물을 제조하는 개량방법
FI850215A0 (fi) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl- n-furyl(eller tienyl)-metylpropylaminer.
KR830006285A (ko) 벤조퀴놀리진의 제조방법
KR830002778A (ko) 결정화 방법
KR830001890A (ko) 카바졸 유도체의 제조방법
KR850002973A (ko) 시티딘 유도체의 제조방법
KR890002011A (ko) 5-할로 게노-6-아미노-니코틴산 할라이드. 이의 제조방법 및 용도
KR860008184A (ko) 디옥솔로벤조이소옥사졸 유도체의 제법
KR840001122A (ko) 플루오르화 디아미노-헵텐 및-헵틴 유도체의 제조방법
KR830005193A (ko) 5-설파모일-오르타닐산의 제조방법
KR830001924A (ko) 퀴나졸린 항고혈압제
KR830005231A (ko) 이미다졸 유도체의 제조방법
KR840004105A (ko) N,n- 치환된 아졸 카복스 아미드 유도체의 제조방법
KR860002454A (ko) 살리실아미드 유도체의 제조방법

Legal Events

Date Code Title Description
A107 Divisional application of patent
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19941011

Year of fee payment: 11

EXPY Expiration of term